PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection

Journal of Viral Hepatitis

Volumn 17, Issue 7, 2010, Pages 453-458

  Watanabe, T ^a,b   Bertoletti, A ^a,c,d   Tanoto, T A ^a,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

HBV; HCV; PD 1; PD L1; T cell

Indexed keywords

B LYMPHOCYTE RECEPTOR; B7 ANTIGEN; CD28 ANTIGEN; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; APOPTOSIS REGULATORY PROTEIN; CD274 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

CHRONIC HEPATITIS; CYTOKINE RELEASE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS HEPATITIS; VIRUS LOAD; BIOLOGICAL MODEL; IMMUNOLOGY; LYMPHOCYTE DEPLETION; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, CD274; APOPTOSIS REGULATORY PROTEINS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LYMPHOCYTE DEPLETION; MODELS, BIOLOGICAL; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES;

EID: 77953575514     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01313.x     Document Type: Review

References (58)

1. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002 5 (Suppl 1) S21-S29.
2. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 (2) 507-539.
3. Asabe S, Wieland SF, Chattopadhyay PK et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 2009 83 (19) 9652-9662.
4. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Mol Virol 2006 6 : 1439-1449.
5. Boni C, Fisicaro P, Valdatta C et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007 81 (8 4215 4225.
6. Tan AT, Loggi E, Boni C et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 2008 82 (22) 10986-10997.
7. Thimme R, Wieland S, Steiger C et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003 77 (1) 68-76.
8. Penna A, Pilli M, Zerbini A et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007 45 (3) 588-601.
9. Kaplan DE, Sugimoto K, Newton K et al. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 2007 132 (2) 654-666.
10. Urbani S, Amadei B, Fisicaro P et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006 44 (1) 126-139.
11. Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, Ray SC. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 2005 42 (1) 104-112.
12. Lauer GM, Barnes E, Lucas M et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 2004 127 (3) 924-936.
13. Shoukry NH, Grakoui A, Houghton M et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003 197 (12) 1645-1655.
14. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 (10) 1395-1406.
15. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 (9) 1499-1512.
16. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 (4) 933-941.
17. Cooper S, Erickson AL, Adams EJ et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999 10 (4) 439-449.
18. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996 98 (3) 706-714.
19. Diepolder HM, Zachoval R, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 (8981) 1006-1007.
20. Lopes AR, Kellam P, Das A et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008 118 (5) 1835-1845.
21. Das A, Hoare M, Davies N et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008 205 (9) 2111-2124.
22. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U. Natural regulatory T cells and persistent viral infection. J Virol 2008 82 (1) 21-30.
23. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007 7 (12) 804-813.
24. Kaplan DE, Ikeda F, Li Y et al. Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 2008 48 (6) 903-913.
25. Ebinuma H, Nakamoto N, Li Y et al. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 2008 82 (10) 5043-5053.
26. Muhlbauer M, Fleck M, Schutz C et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol 2006 45 (4) 520-528.
27. Sheppard KA, Fitz LJ, Lee JM et al. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 2004 3 : 37-41.
28. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 2001 98 (24) 13866-13871.
29. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001 2 (3) 261-268.
30. Barber DL, Wherry EJ, Masopust D et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006 439 (7077) 682-687.
31. Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 2007 178 (5) 2714-2720.
32. Petrovas C, Casazza JP, Brenchley JM et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006 203 (10) 2281-2292.
33. Day CL, Kaufmann DE, Kiepiela P et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006 443 (7109) 350-354.
34. Trautmann L, Janbazian L, Chomont N et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006 12 (10) 1198-1202.
35. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007 81 (17) 9249-9258.
36. Fisicaro P, Valdatta C, Massari M et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010 138 (2) 682-693.
37. Radziewicz H, Ibegbu CC, Fernandez ML et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007 81 (6) 2545-2553.
38. Nakamoto N, Kaplan DE, Coleclough J et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008 134 (7) 1927-1937.
39. Boettler T, Panther E, Bengsch B et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 2006 80 (7) 3532-3540.
40. Zhang Z, Jin B, Zhang JY et al. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients. J Hepatol 2009 50 (6) 1163-1173.
41. Zhang Z, Zhang JY, Wherry EJ et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008 134 (7) 1938-1949.
42. Urbani S, Amadei B, Tola D et al. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 2008 48 (4) 548-558.
43. Kassel R, Cruise MW, Iezzoni JC, Taylor NA, Pruett TL, Hahn YS. Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology 2009 50 (5) 1625-1637.
44. Velu V, Titanji K, Zhu B et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009 458 (7235) 206-210.
45. Franceschini D, Paroli M, Francavilla V et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 2009 119 (3) 551-564.
46. Gehring AJ, Ho ZZ, Tan AT et al. Profile of tumor antigen-specific CD8 T Cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2009 137 (2) 682-690.
47. Blackburn SD, Shin H, Haining WN et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009 10 (1) 29-37.
48. Jones RB, Ndhlovu LC, Barbour JD et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008 205 (12) 2763-2779.
49. Golden-Mason L, Palmer BE, Kassam N et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009 83 (18) 9122-9130.
50. Nakamoto N, Cho H, Shaked A et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009 5 (2) e1000313.
51. Bukczynski J, Wen T, Ellefsen K, Gauldie J, Watts TH. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. Proc Natl Acad Sci USA 2004 101 (5) 1291-1296.
52. Sabbagh L, Srokowski CC, Pulle G et al. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci USA 2006 103 (49) 18703 18708.
53. Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. J Immunol 2007 179 (12) 8252-8263.
54. Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000 192 (7) 1027-1034.
55. Lichterfeld M, Yu XG, Mui SK et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol 2007 81 (8) 4199-4214.
56. Neveu B, Debeaupuis E, Echasserieau K et al. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology 2008 48 (3) 713-722.
57. Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T et al. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 2008 82 (6) 3154-3160.
58. Rutebemberwa A, Ray SC, Astemborski J et al. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 2008 181 (12) 8215-8225.